Today, 6th March is European Swallowing Awareness Day. Research has shown that up to 60% of patients suffer from swallowing difficulties following treatment for head and neck cancer which is a serious issue as numbers of new cases are increasing at a relentless rate.
Oracle Cancer Trust have funded significant research projects to reduce issue with swallowing as far back as 2005 under the supervision of Professor Chris Nutting who developed the pioneering form of radiotherapy, known as IMRT. Previous studies have shown a reduction from 90% of patients experiencing swallowing problems to less than 20% using these revised techniques. Oracle is currently funding a three-year project at The Royal Marsden Hospital to reduce the impact of radiotherapy on the swallowing function.
Oracle also funded Dr Justin Roe, Joint Head of Speech and Language Therapy at The Royal Marsden Hospital who’s funded work on swallowing outcomes in patients was awarded a prestigious prize at the 24th Annual Dysphagia Research Society Meeting.